01 2DICLOFENAC SODIUM
02 2MISOPROSTOL
03 1TRANEXAMIC ACID
01 1TABLET
02 4TABLET (DELAYED-RELEASE)
01 2200MCG
02 1500MG
03 150MG
04 175MG
01 2GD-DICLOFENAC/MISOPROSTOL 50
02 2GD-DICLOFENAC/MISOPROSTOL 75
03 1GD-TRANEXAMIC ACID
Regulatory Info : Prescription
Registration Country : Canada
Genmed A Division Of Pfizer Canada Inc
Dosage Form : TABLET (DELAYED-RELEASE)
Dosage Strength : 50MG
Packaging : 250
Brand Name : GD-DICLOFENAC/MISOPROSTOL 50
Approval Date :
Application Number : 2341689
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Genmed A Division Of Pfizer Canada Inc
Dosage Form : TABLET (DELAYED-RELEASE)
Dosage Strength : 200MCG
Packaging : 250
Brand Name : GD-DICLOFENAC/MISOPROSTOL 50
Approval Date :
Application Number : 2341689
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Genmed A Division Of Pfizer Canada Inc
Dosage Form : TABLET (DELAYED-RELEASE)
Dosage Strength : 75MG
Packaging : 250
Brand Name : GD-DICLOFENAC/MISOPROSTOL 75
Approval Date :
Application Number : 2341697
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Genmed A Division Of Pfizer Canada Inc
Dosage Form : TABLET (DELAYED-RELEASE)
Dosage Strength : 200MCG
Packaging : 250
Brand Name : GD-DICLOFENAC/MISOPROSTOL 75
Approval Date :
Application Number : 2341697
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Genmed A Division Of Pfizer Canada Inc
Dosage Form : TABLET
Dosage Strength : 500MG
Packaging : 100
Brand Name : GD-TRANEXAMIC ACID
Approval Date :
Application Number : 2409097
Regulatory Info : Prescription
Registration Country : Canada
LOOKING FOR A SUPPLIER?